/PRNewswire/ Bened Biomedical announced recent approval of the company s probiotic L. plantarum PS128 in Thailand and Canada. Authorities in each country.
A demonstrative policy debate event on whether e-cigarettes should be regulated was held on Tuesday in Taipei, showing how different public policy viewpoints can be rationally discussed.
The debate was held by the Chinese Debate Promotion Association (CDPA) at the Taipei NGO House.
CDPA chairman and founder Chia Pei-te (賈培德) said that the Executive Yuan in January approved a draft amendment to the Tobacco Hazards Prevention Act (菸害防制法) proposed by the Ministry of Health and Welfare, for legislative review.
The proposed regulations on emerging tobacco products have sparked discussions, he added.
The amendment would classify emerging tobacco products as “tobacco-like products” and “designated
Psychobiotic PS128 consumption shows benefits to Parkinson s symptoms in new clinical study
News provided by
Share this article
Share this article
TAIPEI, Feb. 18, 2021 /PRNewswire/ Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study for its PS128 psychobiotic in treating symptoms of Parkinson s disease (PD). The study was led by a neurologist, Dr. Chin-Song Lu, a renowned researcher for PD in Taiwan.
R&D team of Bened Biomedical
Psychobiotics are probiotics which yield specific mental health benefits. PS128, a strain of
Lactobacillus plantarum, is able to modulate dopamine and serotonin neurotransmitter levels. When these levels are abnormal, conditions such as autism spectrum disorder (ASD), depression, and PD can arise. In separate prior studies, PS128 has been shown to be effective against autism and depression.